A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection

BACKGROUND & AIMS: In Taiwan, patients with chronic hepatitis C virus (HCV) infection are currently treated with pegylated interferon‐alpha plus ribavirin, but interferon‐based regimens can be poorly tolerated, especially by those with advanced liver disease and the elderly. Sofosbuvir, an oral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Liver Int
Main Authors: Kao, Jia‐Horng, Chien, Rong‐Nan, Chang, Ting‐Tsung, Peng, Cheng‐Yuan, Hu, Tsung‐Hui, Lo, Gin‐Ho, Wang, Horng‐Yuan, Chen, Jyh‐Jou, Yang, Jenny C., Knox, Steven J., Han, Lingling, Mo, Hongmei, Mathias, Anita, Brainard, Diana M., Sheen, I‐Shyan, Hsu, Yu‐Chun, Chu, Chi‐Jen, Chuang, Wan‐Long
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Viral Hepatitis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5071670/
https://ncbi.nlm.nih.gov/pubmed/26835876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13082
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados